Liberum Capital issued a report on Genus PLC (LON:GNS), keeping its stock price target at 1,950.00GBX today
- Updated: September 25, 2016
Having a price of 1,929.00GBX, Genus PLC (LON:GNS) traded -2.23% lower on the day. With the last stock price up 16.34% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. GNS has recorded a 50-day average of 1,898.97GBX and a two hundred day average of 1,656.40GBX. Trade Volume was down over the average, with 4,272 shares of GNS changing hands under the typical 71,996
In a report released on 9/26/2016 Liberum Capital hold steady the target price of Genus PLC (LON:GNS) from 1,950.00GBX to 1,950.00GBX stating a potential upside of 0.01%.
On 9/20/2016, N+1 Singer released a statement about Genus PLC (LON:GNS) upped the target price from 1,429.00GBX to 2,019.00GBX that suggested an upside of 0.01%.
Recent Performance Chart
Genus PLC has PE ratio of 24.00 with a one year low of 1,281.00GBX and a one year high of 2,056.00GBX and has a market capitalization of 0 GBX.
A total of 5 firms have issued a report on GNS. One brokerage rating the stock a strong buy, one brokerage rating the company a buy, 4 brokerages rating the stock a hold, 0 firms rating the stock a underperform, and finally zero analysts rating the company a sell with a one year target of 1,485.60GBX.
Brief Synopsis About Genus PLC (LON:GNS)
Genus plc is a United Kingdom-based animal genetics company. The Company provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company's segments are Genus PIC, Genus ABS and Genus Asia. The Genus PIC segment serves porcine customers in North America, Latin America and Europe. The Genus ABS segment serves dairy and beef customers in North America, Latin America and Europe. The Genus Asia segment serves porcine, dairy and beef customers in Asian markets. The Company breeds and distributes genes of pigs and bulls. In the porcine market, the Company sells genetically boars and sows that produce offspring with characteristics, such as growth or leaner meat. In the dairy and beef markets, the Company's primary product is bull semen, which is delivered through artificial insemination. The Company also offers genetically superior embryos through its subsidiary, In Vitro Brasil S.A.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.